Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
49
pubmed:dateCreated
2000-2-3
pubmed:abstractText
Mutant presenilins (PS) contribute to the pathogenesis of familial Alzheimer's disease (FAD) by enhancing the production of Abeta42 from beta-amyloid precursor protein. Presenilins are endoproteolytically processed to N-terminal and C-terminal fragments, which together form a stable 1:1 complex. We have mapped the cleavage site in the PS2 protein by direct sequencing of its C-terminal fragment isolated from mouse liver. Three different N-terminal residues were identified starting at Val-299, Thr-301, and Leu-307 that correspond closely to the previously described N termini of the C-terminal fragment of human PS1. Mutational analysis of the PS2 cleavage site indicates that the principal endoproteolytic cleavage occurs at residues Met-298/Val-299 and that the N terminus is subsequently modified by secondary proteolytic cleavages. We have generated cleavage defective PS2 constructs, which accumulate exclusively as full-length polypeptides in transfected Neuro2a cells. Functional analysis of such cleavage defective PS2 carrying the FAD mutation Asn-141 --> Ile showed that its Abeta42 producing activity was strongly reduced compared with cleavage-competent FAD PS2. In contrast, cleavage defective PS2 was active in rescuing the egg-laying defect of a sel-12 mutant in Caenorhabditis elegans. We conclude that PS2 endoproteolytic cleavage is not an absolute requirement for its activities but may rather selectively enhance or stabilize its functions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
3
pubmed:volume
274
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
35233-9
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:10575009-Alzheimer Disease, pubmed-meshheading:10575009-Amino Acid Sequence, pubmed-meshheading:10575009-Amyloid beta-Peptides, pubmed-meshheading:10575009-Animals, pubmed-meshheading:10575009-Animals, Genetically Modified, pubmed-meshheading:10575009-Caenorhabditis elegans, pubmed-meshheading:10575009-Cells, Cultured, pubmed-meshheading:10575009-Humans, pubmed-meshheading:10575009-Membrane Proteins, pubmed-meshheading:10575009-Mice, pubmed-meshheading:10575009-Molecular Sequence Data, pubmed-meshheading:10575009-Mutagenesis, Insertional, pubmed-meshheading:10575009-Mutagenesis, Site-Directed, pubmed-meshheading:10575009-Peptide Fragments, pubmed-meshheading:10575009-Precipitin Tests, pubmed-meshheading:10575009-Presenilin-2, pubmed-meshheading:10575009-Promoter Regions, Genetic, pubmed-meshheading:10575009-Sequence Homology, Amino Acid, pubmed-meshheading:10575009-Tissue Distribution, pubmed-meshheading:10575009-Transfection
pubmed:year
1999
pubmed:articleTitle
The influence of endoproteolytic processing of familial Alzheimer's disease presenilin 2 on abeta42 amyloid peptide formation.
pubmed:affiliation
Pharma Division, Preclinical Central Nervous System Research, CH-4070 Basel, Switzerland. helmut.jacobsen@roche.com
pubmed:publicationType
Journal Article